HFA Premium Access

Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish Heart Failure Registry

Congress Presentation

About the speaker

Assistant Professor Peter Moritz Becher

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
0 follower

4 more presentations in this session

Role of urinary potassium to creatinine ratio for tailoring the type of diuretic regimen in patients with acute heart failure and diuretic resistance

Speaker: Doctor F. Croset (Madrid, ES)

Thumbnail

Heart failure is the cancer for the heart: the prognostic importance of the new HLM classification

Speaker: Doctor A. D'Amato (Rome, IT)

Thumbnail

Impact of obstructive sleep apnea in patients undergoing left ventricular assist device implantation

Speaker: Doctor N. Patel (Hartford, US)

Thumbnail

Clinical, laboratory associates and prognostic significance of hypocapnia in acute heart failure. 

Speaker: Mr M. Garus (Wroclaw, PL)

Thumbnail

Access the full session

Acute heart failure: treatment and prognosis

Speakers: Assistant Professor P. Becher, Doctor F. Croset, Doctor A. D'Amato, Doctor N. Patel, Mr M. Garus
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb